Form 4 for NPCE NeuroPace Inc
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-20 · accession 0001628280-26-020837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | 2026-03-20 | NPCE | Geiger Uri | Dir | A - Grant | $13.00 | +913 | 14.9K | +7% | +$11.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-20 | A | A | 913 | $13.00 | 14,858 | D | — | — | (F1) These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |